Subscribe to RSS - Fisher & Paykel

Fisher & Paykel

F&P increases guidance, in part due to coronavirus outbreak


IRVINE, Calif. – Fisher & Paykel Healthcare has updated its revenue and earnings guidance for the financial year ended March 31, 2020, due to better-than-expected sales in its home care product group.

In brief: OIG finds large recovery, F&P reports growth


WASHINGTON – Taxpayers could see nearly $5.9 billion that has been misspent on healthcare services returned to the government, according to The Office of Inspector General in its Semiannual Report to Congress published last week.

Fisher & Paykel reports growth


AUCKLAND, New Zealand – Fisher & Paykel Healthcare reported net profit after tax of $121.2 million for the six months ended Sept. 30, representing 24% growth.

The company reported operating revenue of $570.9 million, representing 12% growth.

In brief: F&P upgrades guidance, NSM creates ‘Chill Spot’


IRVINE, Calif. – Fisher & Paykel Healthcare has upgraded its guidance for the financial year ending March 31, 2020, to full operating revenue of about $1.17 billion and net profit after tax of about $245 million to $255 million.

F&P hits revenue milestone


IRVINE, Calif. – Fisher & Paykel Healthcare reported NZ$421.5 million in operating revenue for its homecare product group for the 2019 financial year, representing 6% growth or 4% growth in constant currency.

COPD researcher receives grant


NEW YORK – Spyridon Fortis, MD, of the Carver College of Medicine at the University of Iowa has received the ATS Foundation/Fisher & Paykel Healthcare Research Award in Respiratory Support with Nasal High Flow Patients with CODP. The $100,000 award will help fund Dr.

F&P responds to ResMed


IRVINE, Calif. – Fisher & Paykel Healthcare has filed a complaint with the U.S. International Trade Commission seeking an exclusion order to prevent the import and sale of ResMed’s AirFit P10 range of nasal pillows masks in the United States.

Growth was off for F&P Healthcare’s masks


IRVINE, Calif. – Fisher & Paykel Healthcare reported operating revenue grew 10% to a record NZD 980.8 million, or 9% in constant currency terms, for fiscal year 2018.

In brief: Mulvaney comments on IFR, AAH plans response to tariffs


WASHINGTON – Office of Management and Budget Director Mick Mulvaney said last week that the agency is working to release an interim final rule that would provide relief from Medicare’s competitive bidding program, but he gave no timeline for when that might happen.

F&P wins patent case in UK


AUCKLAND, New Zealand – The English Patents Court has sided with Fisher & Paykel Healthcare, saying a ResMed patent for masks is invalid in the U.K.